The suppressor of cytokine signalling-3 (SOCS3) is well known as a feedback inhibitor of the Janus kinases-signal transducer and activator of transcription 3 (JAK/STAT3) signalling pathway, which mediates the signal transduction of many cytokines, growth factors and hormones during many cellular processes.
| INTRODUCTION
The Janus kinase-signal transducers and activators of transcription (JAK-STAT) signalling pathway has been shown to play a critical role in many biological processes, including cell activation, proliferation, differentiation, apoptosis and angiogenesis. [1] [2] [3] [4] [5] The JAK-STAT pathway is activated by a large number of hormones, growth factors and cytokines. Cytokines are a category of small proteins or peptides with a molecular weight of 5-30 KD which plays essential roles during the development of the immune system, hematopoiesis, inflammation and innate and adaptive immune responses. 6, 7 Immune cells produce cytokines which regulate inflammation, are essential for trauma response, infections, but also the key components of autoimmune disease and embryonic development. 8 Excessive cell stimulation by cytokines can be detrimental to the organism by causing inflammation-mediated tissue damage as inadequate stimulation lead to uncontrolled infections. The suppressor of cytokine signalling (SOCS) proteins family has been described as the classical negative regulator of cytokine receptor signalling of the JAK/STATs pathway and consists of eight structurally similar proteins. 1, 9 Among them, the SOCS3 protein is well known as a feedback inhibitor of the JAK/STAT3 pathway through binding to its corresponding receptor, primary receptor shared interleukin-6 (IL-6) receptor subunit gp130, to inhibit STAT3 phosphorylation.
| STATS FAMILY AND JAK/STATS SIGNALLING PATHWAY
The STAT family contains seven members, comprising a unique class of transcription factors with a length between 750 and 850 amino acids (aa). The STAT family is characterized by the presence of four functional domains ( Figure 1 ): 1, a Src homology 2 (SH2) domain, which could specifically recognize the phosphorylated state of tyrosine residues at its corresponding cytokine receptors; 2, a C-terminal transactivation site, which includes the tyrosine-phosphorylated sites; 3, a amino acid with a length between 400 and 500 aa that determines the DNA-binding site; 4, a coiled-coil structure that presents a predominantly hydrophilic surface area for interaction with other proteins. 14, 15 The JAK/STATs system consists of three main components: 1. a receptor; 2. JAK kinases including TYK2, JAK1, JAK2 and JAK3; 3. STAT proteins. 16 Cytokines binding to their respective receptors induce the aggregation of receptors, resulting in the activation of JAKs via crossphosphorylation. 17, 18 Activated JAKs phosphorylate the cytokine receptors on their tyrosine residues (p-Tyr or pSer) to create the binding site for SH2 domain on STATs (JAK/STAT pathways in cytokine signalling and myeloproliferative disorders). The phosphorylated STATs will dissociate from the receptor and mediate dimerization, resulting in the formation of either hetero-or homo-dimers. The STAT dimers will enter the nucleus, where they bind to specific DNA sequences in the promoter region of their target genes, regulating transcription. 19, 20 The JAK/STATs signalling pathway mediates the signal transduction of many cytokines, growth factors, and hormones during numerous cellular processes, 19, 20 and different cytokines that mediate the corresponding signalling via JAK/STATs signalling pathway 2, [21] [22] [23] [24] [25] [26] [27] [28] are shown in Table 1 . Interestingly, the same type of STATs might render different biological consequences. The excessive stimulation mediated by cytokine-induced JAK/STATs signalling has been linked to several immune diseases. 29 For example, multiple sclerosis (MS) is related to the dis-regulation of STAT1, STAT3 and STAT4 activation, mediating the focal inflammatory infiltration into the central nervous system (CNS), demyelinating lesions and pro-inflammatory cytokines production, which activates immune cells and damages neurons and oligodendrocytes. 30 Thus, tight control of JAK/STATs pathways is necessary to avoid the detrimental consequences of a pathogenic over stimulation.
| SOCS FAMILY
There are three classic inhibitors that contribute to the negative regulation of JAK/STAT-mediated cytokine signalling, phosphotyrosine phosphatases (PTPs), protein inhibitors of activated STAT (PIAS) and SOCS proteins. 31, 32 SOCS proteins are thought to be the principal regulators of JAK/STATs signalling, having been proven to widely regulate over 30 cytokines, such as leukaemia inhibitory factor (LIF), granulocyte colony-stimulating factor (G-CSF), interferon-γ (IFN-γ), IL-6, and IL-10. 9, 33 The SOCS proteins family consists of eight proteins, including SOCS1-7 and cytokine-inducible SH2-containing protein (CIS), [34] [35] [36] which share a similar architecture that includes two functional domains: 1, a central SH2 domain, which binds to the defined tyrosine-phosphorylated substrates on the cytokine receptor and 2, a SOCS-box domain at their C-terminus, which binds to elongins B and C and cullin 5, leading to the ubiquitination and degradation of their corresponding receptors, [37] [38] [39] as shown in Figure 2 . The two most well-known members of the SOCS family, SOCS1 STAT6 IL-4 and IL-13 [28] and SOCS3, act through an additional mechanism: they use a short motif, named the kinase-inhibitory region (KIR) absent in the other members, to restrain signalling transmission by directly inhibiting the catalytic activity of JAKs. 46 Accumulated data have proven that STAT3 could be activated by tyrosine phosphorylation (P-Tyr705) via JAKs, which could lead to the p-STAT3 dimerization through reciprocal phosphotyrosine-SH2 domain interactions. The dimers will further translocate into the nucleus and bind to specific DNA elements to induce gene expression. Additionally, STAT3 can be activated by serine phosphorylation (p-Ser727) within the transactivation domain, which is mediated by several serine kinases such as ERK1, ERK2, p38 and JNK. 47, 48 STAT3 is involved in a broad range of biological events within different tissues and cell populations, including acute-phase responses induced by IL-6 in liver, embryogenesis, cell growth and differentiation, pro-inflammatory and anti-inflammatory responses, hematopoiesis and tumour survival. 45, [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] Structure-function studies have revealed the mechanism by which SOCS3 inhibits IL-6/JAK2/STAT3 signalling, which is involved in many immune diseases and cancer. 49 Nadia et al showed the crystal structure of a ternary complex between mouse SOCS3, JAK2 and a fragment of the IL-6 receptor β-chain, demonstrating that SOCS3 could bind to JAK2 and their receptors at the same time with two opposing regions (SH2 domain and kinase-inhibitory region). SOCS3 inhibits the catalytic activity of JAK2 in two ways: 1. phosphotyrosine-binding groove on the SOCS3 SH2 domain occupies the receptor, then JAK2 can only bind to a non-canonical surface in a phospho-independent manner; and 2. KIR of SOCS3 occludes the substrate-binding groove on JAK2 and thereby blocks substrate association, 63 as shown in Figure 3 .
During immune responses, the JAK2/STAT3 pathway can be activated by IL-6 and IL-10 to induce pro-inflammatory or anti-inflammatory responses, respectively. [64] [65] [66] The role of STAT3 in infection and inflammatory diseases has been investigated by using a stat3 gene conditional knockdown mouse model. Since SOCS3 cannot bind to the IL-10 receptor, it has been suggested that the modulation by SOCS3 of the IL-6 but not the IL-10 signalling pathway is responsible for this different immune response utilizing the same pathway. 67 Accordingly, IL-6 responses resemble those of IL-10 responses in the absence of SOCS3. 
| SOCS3 and STAT3 in myeloid cells
In macrophages, SOCS3 can be strongly induced by lipopolysaccharide (LPS), IL-6 and IL-10. [69] [70] [71] [72] Mice that are deficient for SOCS3 in their myeloid cells (LysMCre-SOCS3 fl/fl mice) showed higher plasma levels of proinflammatory M1 cytokines such as IL-1β, tumour necrosis factor-α (TNF-α) and IL-6 which correlated with the prolonged STAT3 activation in an LPS-mediated sepsis model. 73 In contrast, mice with a conditional knockdown or a mutation of the SOCS3 binding site in macrophages are resistant to endotoxemia due to a reduced production of inflammatory cytokines, indicating that SOCS3 blocks explicitly IL-6-induced anti-inflammatory response through STAT3 phosphorylation.
68
SOCS3 is linked to inflammation and autoimmune diseases, such as inflammatory bowel disease (IBD) and multiple sclerosis (MS). 49 IBD is characterized by chronic inflammation of the gastrointestinal tract and is subdivided into two dominant phenotypes: Crohn's disease (CD) and ulcerative colitis (UC). IBD is one of the classic autoimmune diseases, in which the immune system attacks elements of the digestive system. 74, 75 Intestinal macrophages and dendritic cells (DCs) form a unique group of tissue immune cells that are ideally situated at the interface of the host and the enteric luminal environment to appropriately respond to microbes and other potential stimuli. 76 High levels of SOCS3 expression potentially blocks STAT3 both in mouse IBD model and human patients. 50, 77 Mice with a conditional knockdown of STAT3 in macrophages displayed increased levels of inflammatory cytokines (TNF-α and IL-12p40) and developed chronic enterocolitis reminiscent of human IBD. 51, 52 Additionally, mice with a conditional knockdown of STAT3 in myeloid cells (Stat3 flox/ flox LysMcre) developed chronic enterocolitis reminiscent of human IBD, with increased levels of inflammatory cytokines (TNF-α, IL-6, IL-12, and IFN-γ) from macrophages and DCs. In vitro experiments showed that the suppressive effects of IL-10 on inflammatory cytokine production were utterly eliminated in bone marrow-derived macrophages or peritoneal macrophages from Stat3 mutant mice. 51, 52 However, development of colitis, as well as STAT3 activation, was significantly reduced in IL-6-deficient mice treated with dextran sodium sulphate (DSS), suggesting that STAT3 plays a vital role in the perpetuation of colitis. 50 Experimental allergic encephalomyelitis (EAE), an inflammatory demyelinating disease of the CNS, is an animal model of brain inflammation of human nervous system demyelinating diseases, including MS. 78 By using a myelin oligodendrocyte glycoprotein-induced mouse model of MS, EAE, Qin et al demonstrated that mice with a SOCS3 deletion in macrophages exhibited enhanced STAT3 signalling, which led to the classical M1 macrophage polarization. 54 They further found that the severity of EAE can be decreased by intravenous injection of M2 macrophages or SOCS3-overexpressing DCs. 54 Conversely, mice transferred with SOCS3-deficient DCs developed less severe EAE, suggesting that SOCS3-deficient DCs are immunosuppressive or less able to stimulate autoimmune responses in vivo. 53 Similarly, Saeki et al found that SOCS3 was involved in macrophage activation and enhanced the severity of pancreatitis. Expression levels of co-stimulatory molecules CD80 and CD86 were upregulated due to the enhanced nuclear factor NFκB activation due to SOCS3-mediated inhibition of the IL-6/STAT3 pathway. 55 Kuuliala et al's signalling profiled the blood myeloid cells in acute pancreatitis (AP) with organ dysfunction (OD) to evaluate the relation to disease severity. The results showed that the fluorescence intensity of pSTAT3 in monocytes was lower in AP patients with OD than in AP patients without OD, suggesting that STAT3 pathway provides novel markers. 
| SOCS3 and STAT3 in lymphoid cell
STAT proteins and SOCS family members have been described as the necessary regulators for T helper (Th) cell differentiation, 83 as shown in Figure 4 .
F I G U R E 3 SOCS3 binding sites on JAK and receptor
Th17 cells have been distinguished as one of the significant pathogenic T cell subpopulations underlying the development of several autoimmune diseases. 84 
STAT3
activation in response to IL-6 in combination with transforming growth factor-β (TGF-β) and IL-23 lead to an upregulated expression of RAR-related orphan receptor-γt (RORγt), which is the signature transcription factor for Th17 cells. 85 Th17 cells secrete cytokines IL-17A, IL-17F, IL-21 and IL-22, which are pro-inflammatory. SOCS3 has been shown to negatively regulate IL-23-mediated STAT3 phosphorylation and Th17 polarization, 86 which could bind to both the IL-17A and IL-17F promoter. 87 By using overexpression models, SOCS3 also has been implicated as a regulator of Th1/2 polarization via its ability to inhibit IL-12-induced STAT4 activation. 88, 89 However, Chen et al 90 found that a deficiency for SOCS3 had little effect on Th1/ 2 polarization. The hyper IgE syndrome (HIES) is a primary immune deficiency characterized by elevated serum IgE, rash and recurrent staphylococcal infections of the skin and lung. It is believed that autosomal dominant HIES results from STAT3 hypomorphic mutations and has a variety of connective tissue and skeletal abnormalities. 58 In some cases, hematopoietic cell transplantation can potentially reduce the severity of HIES. 57 Further, a STAT3 mutant mouse with HIES was constructed, and Scott et al found out that bone marrow transplantation partly reduced the heightened inflammatory responses with high levels of IL-6, TNF-α, IL-12 and IFN-γ due to a non-efficient STAT3/ IL-10 anti-inflammatory pathway. 91 At the same time, it is believed that STAT3 has a critical pro-inflammatory role, since it is required for Th17 differentiation as well as IL-17 and IL-22 secretion, ensuring the antimicrobial peptide regenerating islet-derived protein 3 γ (Red3 γ) production and control of the recurrent Citrobacter rodentium infections seen in HIES. 91 In HIES, Th17 cells are deficient and have increased susceptibility to infections in the case of mutations of IL-17 or RORγt. 56 Yu et al found that mice with a SOCS3 deletion in T cells were protected from experimental autoimmune uveitis (EAU). Protection from EAU correlated with enhanced expression of CTLA-4 and expansion of IL-10-producing regulatory T cells with augmented suppressive activities. Moreover, double-producing Th17/IFN-γ CD4 T cell populations were reduced in mice deficient for SOCS3 in T cells, suggesting that SOCS3 promotes the expansion of the Th17/IFN-γ subset associated with the development of severe uveitis. Thus, SOCS3 is a potential therapeutic target in uveitis and other auto-inflammatory diseases. Loss of SOCS3 in T cells during atherosclerosis increased both IL-17 and IL-10 production and led to an unexpected IL-17-dependent reduction in lesion development and vascular inflammation. This reduction identified a novel SOCS3-controlled IL-17 regulatory pathway in atherosclerosis and may have important implications for the understanding of the increased susceptibility to vascular inflammation in patients with dominant-negative STAT3 mutations and defective Th17 cell differentiation. 93 B cells play an important role in the pathogenesis of primary Sjögren's syndrome (pSS). Imgenberg-Kreuz et al analyzed the transcriptome of CD19 + B cells from pSS patients and found out that the expression of SOCS3 was downregulated, possibly permitting a more pro-inflammatory state in pSS. 94 In addition, IL-17 has been shown to be involved in the control of MTB infection. 81 The frequency of Th17 Intestinal inflammation caused by pathogenic bacteria is a frequent and potentially life-threatening disease. 97 A meta-analysis of CD and ulcerative colitis genomewide association scans have connected the transcription factor STAT3, which is widely expressed by different tissues and cell types, to intestinal pathology. 98 Backert et al found that STAT3 in T cells mediated a protective role on intestinal epithelial cells (IECs) during infectious colitis. STAT3 promotes the Th17, Th22 cell differentiation and IL-17, IL-22 secretion, which stimulates IECs and promotes protection from enteropathogenic bacteria through maintenance of high induction antimicrobial peptides. 
| SOCS3 and STAT3 in Non-

Hematopoietic cells
SOCS3 and STAT3 also play important physiological roles in non-hematopoietic cells such as thymic epithelial cells, neurons, muscle cells, hepatocytes, fibroblasts and adipocytes. For example, SOCS3 controls neurite outgrowth in dorsal root ganglia, insulin resistance in adipocytes, and is associated with age-related blunted muscle stem cell responses. 100 Meanwhile, they are also connected with corresponding infections and inflammatory diseases.
| STAT3 in Thymic epithelial cells
T cell development in the thymus depends on the crosstalk between thymocytes and stromal cells including epithelial cells, macrophages and DCs. 101, 102 Thymic epithelial cells (TECs) are organized in a three-dimensional architecture, the cortex surrounding the medullary regions, where T cell precursors mature and differentiate. 103 Cortical epithelial cells (cTECs) regulate the early and intermediate stages for T cell development, including a commitment of progenitors to the T cell lineage, the proliferation and positive selection of developing thymocytes, selecting only those that could recognize peptides on its own major histocompatibility complex (MHC). 104 Medullary epithelial cells (mTECs) present tissue-restricted self-antigens (TRA) to delete selfreactive T cells and prevent autoimmunity, a process called negative selection. 105, 106 Developing thymocytes and TECs interact in different manners. Thymocytes can express many surfaces or secreted molecules (CD40L, RANKL, LTα and LTβ), which critically control the growth and maturation of TECs.
107-111
Keratin 5 (K5) is expressed in mTECs. Using K5-Cre mice to delete stat3, Satoh et al generated the mouse model with Foxn1-Cre-driven inactivation of the STAT3 locus in TEC and showed that the thymus from juvenile and adult mice showed an average size with a reduced medulla but a normal cortex. 112 More notably, Lomada et al provided a transgenic mouse model with the constitutively active STAT3 transgene (K5.Stat3C) which is highly expressed in the thymic medulla, resulting in selective expansion of MHCII lo CD80 lo immature mTECs. In summary, the phenotypes from previous studies generated by enforcing or preventing stat3-mediated signalling in TECs reveal that STAT3 activation plays a key role in TECs maintenance and T cell development in the thymus, but this needs more precise studies. 113 Li et al found out that inflammatory cytokines such as IL-6, IL-8 and ICAM1 could be downregulated by Fra1 in medulla thymic epithelial cell line, and STAT3 and SOCS3 were highly upregulated along with protein in the thymus of myasthenia gravis patient, which demonstrated that those two proteins are strongly involved in the process of disruption inflammatory cytokine secretion. 
| SOCS3 and STAT3 in Neurons
SOCS3 and STAT3 play important roles in neuronal survival as well as cell death. Mishra et al reported that SOCS3 over-expression upregulated differentiation of both neural stem cells and PC12 cells even in the absence of nerve growth factor (NGF), which confirmed that SOCS3 could promote differentiation and survival of neural cells, and could be potentially useful in future therapy for treatment of neurodegenerative disorders. 115 Hackett et al found out that both STAT3 and SOCS3 play important, yet unexpected, roles in oligodendrocyte progenitors proliferation and differentiation after spinal cord injury. 116 Deep hypothermia therapy (HT) is a standard method for neuroprotection during complicated paediatric cardiac surgery. The procedure, however, can provoke systemic inflammatory response syndrome, one of the most severe side effects associated with paediatric cardiac surgery. Tong et al found out that deep HT resulting in the expressions down-regulation of SOCS3 and p-STAT3, also corresponding with the significant reduction in IL-6 and TNF-α expression, which attenuation of the inflammatory response resulted in decreased apoptosis in a direct co-culture of microglia and neurons. 
| SOCS3 and STAT3 in Muscle cells
Excessive inflammation reduces skeletal muscle protein synthesis leading to wasting and weakness. SOCS3 is important in the control of muscle homoeostasis. Swiderski et al found that muscle-specific deletion of SOCS3 increases the early inflammatory response 118 ; Caldow et al found that in muscles from SOCS3-MKO mice, the SOCS3 mRNA response to LPS was significantly blunted, while STAT3 p-Tyr705 was exacerbated. 119 In human atherosclerotic lesions, vascular smooth muscle cells (VSMCs) and macrophages express SOCS3, which is one of the key regulators of vascular cell responses. 
| SOCS3 and STAT3 in Hepatocytes
Compared to wild-type mice, hepatocyte-specific mice lacking STAT3 have decreased liver inflammation in the liver injury models of injection of carbon tetrachloride 121 and alcohol feeding 122 and an increase in Con A-induced T cell hepatitis 123 or in LPS-induced liver injury models, 124 suggesting that STAT3 in hepatocyte acts as either a proinflammatory or an anti-inflammatory signal is model dependent. STAT3 in myeloid cells does not only inhibits expression levels of pro-inflammatory cytokines, such as TNF-α and IFN-γ, which could induce liver damage and inflammation but also represses the production of hepatoprotective cytokines, such as IL-6 and IL-22 that ameliorate liver injury. 125 Thus, the outcome of myeloid STAT3 on hepatocellular damage is more likely determined by the balance between detrimental and hepato-protective cytokines produced during liver injury. Miller et al showed that endothelial cell-specific mice lacking STAT3 were more susceptible to alcohol-induced liver injury and inflammation, 126 suggesting that endothelial cell STAT3 play critical dual functions of attenuating hepatic inflammation and sinusoidal endothelial cell apoptosis during alcoholic liver injury.
| SOCS3 and STAT3 in Fibroblasts
Stimulation of the cholinergic inflammatory pathway can attenuate collagen-induced arthritis (CIA) and inhibit synovitis by JAK2/STAT3 signalling. The effects of nicotine on SOCS1 and SOCS3 protein expression in fibroblast-like synoviocytes (FLSs) were assayed, and the results indicated that the inhibitory effect of nicotine on inflammatory factors has vanished when the SOCS3 protein expression level was downregulated. Further, the results in CIA mouse model showed that nicotine increased the SOCS3 protein expression level in the synovium and reduced the syndromes of synovitis and bone erosion.
127
IL-6 has been proposed to contribute to the development of rheumatoid arthritis (RA), and Shouda et al found that STAT3 was strongly tyrosine phosphorylated in synovial tissue of RA patients. SOCS3 is also expressed in synovial fibroblasts of RA patients. 
| SOCS3 and STAT3 in Adipocytes
The anorexigenic adipocyte-derived hormone leptin and the orexigenic hormone ghrelin act in opposition to regulate feeding behaviour via the vagal afferent pathways and SOCS3 plays a pivotal role in ghrelin's inhibitory effect on STATS phosphorylation and feeding behaviour.
129 IL-6 is one of the mediators linking obesity-derived chronic inflammation with insulin resistance through activation of STAT3, with subsequent up-regulation of SOCS3. 130 In obesity, increased circulating leptin levels caused the chronic STAT3 activation in the CNS which lead to the development of leptin resistance, whereas chronic IL-6-induced STAT3 activation impairs insulin action in the peripheral organs. 131 Adipocytes secreted leptin by the ratio of the amount of fat that stored in the white adipose tissue and acts on hypothalamic neurons to suppress the food intake and to raise energy consumption. 132 In obesity, there is a positive correlation between the quantity of white adipose tissue and the leptin levels, but the protein does not convey its biological effect. The expression level of SOCS3 in the CNS is mostly increased, [133] [134] [135] and mice lacking SOCS3 in hypothalamic neurons are protected from the formation of diet-induced obesity and maintain the critical leptin sensitivity. [136] [137] [138] Palanivel et al also found that mice with deficient SOCS3 expression in adipose tissues were protected against the development of obesity-associated insulin resistance. 
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